Evidence map›Paper›PMID 31881212›Full record

ArticleThe Journal of investigative dermatology2020

Reduction in Human Epidermal Langerhans Cells with Age Is Associated with Decline in CXCL14-Mediated Recruitment of CD14

Tatsuya Hasegawa, Zhaoyi Feng, Zhiyu Yan, Kenneth H Ngo, Junichi Hosoi, Shadmehr Demehri

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Monocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Journal of clinical medicine · 2022
    Review
  11. Article
  12. Article
  13. Circadian protection against bacterial skin infection by epidermal CXCL14-mediated innate immunity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tatsuya HasegawaCenter for Cancer Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Zhaoyi FengCenter for Cancer Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Zhiyu YanCenter for Cancer Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Kenneth H NgoCenter for Cancer Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Junichi HosoiShiseido Global Innovation Center, Yokohama, Japan.
Shadmehr DemehriCenter for Cancer Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: sdemehri1@mgh.harvard.edu.
Harvard University · USShiseido Group (Japan) · JP

Funding

THE MECHANISM OF TSLP ANTI-TUMOR EFFECTS IN THE SKINDP5OD021353 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI DEMEHRI, SHADMEHR · 2015 to 2019
$2.2M
The Role of Allergic Contact Dermatitis in Skin CarcinogenesisK08AR068619 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DEMEHRI, SHADMEHR · 2015 to 2019
$753k
NIAMS NIH HHS K08 AR068619NIH HHS DP5 OD021353
6 · The paper itself

Abstract

The skin provides the first line of physical and immunological defense against environmental insults. However, the age-related changes in the immune function of human skin are unclear. Here, we investigated the age-related changes in epidermal Langerhans cells (LCs), which play a sentinel role in the initiation of the immune responses in the skin. We found a significant reduction in the number of epidermal LCs in sun-protected skin with age. Among the possible explanations for this reduction, the number of CD14

Indexed as

AdultAgedAge FactorsAntigens, CDApoptosisCell CountCell MovementChemokines, CXCCytokinesDendritic CellsEpidermisFemaleHumansKeratinocytesLangerhans CellsLectins, C-TypeAntigens, CDCCR6 protein, humanCD14 protein, humanCD207 protein, humanChemokines, CXCCXCL14 protein, humanCytokinesLectins, C-TypeLipopolysaccharide ReceptorsMannose-Binding LectinsReceptors, CCR6

Identifiers

PMID31881212
PMCPMC8142052
OpenAlexW2998345777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.